Dugger, Debra L.

Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis

Newton, K., Dugger, D. L., Wickliffe, K. E., Kapoor, N., de Almagro, M. C., Vucic, D., Komuves, L., Ferrando, R. E., French, D. M., Webster, J., et al. (2014) · Science

Cell death mechanisms and regulationNF-κB Signaling Pathways

Cited by 687

RIPK1 inhibits ZBP1-driven necroptosis during development

Newton, K., Wickliffe, K. E., Maltzman, A., Dugger, D. L., Strasser, A., Pham, V. C., Lill, J. R., Roose-Girma, M., Warming, S., Solon, M., et al. (2016) · Nature

Cell death mechanisms and regulationNF-κB Signaling Pathways

Cited by 390

Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice

Jumbe, N. L., Xin, Y., Leipold, D. D., Crocker, L., Dugger, D., Mai, E., Sliwkowski, M. X., Fielder, P. J., & Tibbitts, J. (2010) · Journal of Pharmacokinetics and Pharmacodynamics

HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 119

The RIPK4–IRF6 signalling axis safeguards epidermal differentiation and barrier function

Oberbeck, N., Pham, V. C., Webster, J. D., Reja, R., Huang, C. S., Zhang, Y., Roose-Girma, M., Warming, S., Li, Q., Birnberg, A., et al. (2019) · Nature

Skin and Cellular Biology ResearchGenetic and rare skin diseases.

Cited by 86